[Form 4] D-Wave Quantum Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
D-Wave Quantum (QBTS) reported an insider transaction by President & CEO and director Alan Baratz. On 11/11/2025, he exercised stock options for 806,288 shares at $0.91 and sold 806,288 shares at a weighted average price of $28.8686 under a Rule 10b5-1 trading plan adopted on August 11, 2025. The sales occurred in multiple trades between $28.00 and $30.02.
Following the transactions, Baratz directly beneficially owned 2,801,265 shares, which includes 1,110,087 unvested restricted stock units. Derivative holdings reported after the transactions include options for 1,268,107 shares at $0.91 expiring on 05/05/2030, and options for 213,232 shares at $0.846 expiring on 01/10/2034.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 806,288 shares ($23,276,406)
Net Sell
4 txns
Insider
BARATZ ALAN E
Role
President & CEO
Sold
806,288 shs ($23.28M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 806,288 | $0.91 | $734K |
| Exercise | Common Stock, par value $0.0001 per share ("Common Stock") | 806,288 | $0.91 | $734K |
| Sale | Common Stock, par value $0.0001 per share ("Common Stock") | 806,288 | $28.8686 | $23.28M |
| holding | Stock Option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 1,268,107 shares (Direct);
Common Stock, par value $0.0001 per share ("Common Stock") — 3,607,553 shares (Direct)
Footnotes (1)
- The option exercise and sale of Common Stock reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2025. Includes 1,110,087 shares of unvested restricted stock units. The sales price reported is the weighted average sale price for the number of shares of Common Stock sold. These shares were sold in multiple transactions at prices ranging from $28.00 to $30.02, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. This option has fully vested and is exercisable as of the date hereof as to 2,074,395 shares of Common Stock. This option has fully vested and is exercisable as of the date hereof as to 213,232 shares of Common Stock.